The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies—collectively known as plasma protein therapies—and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.
Every year, policymakers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe come together for the plasma protein therapeutics industrys premier European event—the International Plasma Protein Congress (IPPC). The 2018 IPPC will be held March 13-14 in Budapest, Hungary.